Zoetis (ZTS) Interest Expenses (2012 - 2026)
Zoetis (ZTS) posted quarterly Interest Expenses of $62.0 million for Q1 2026, up 14.81% year-over-year from $54.0 million in Q1 2025, and up 2166.67% quarter-over-quarter from -$3.0 million in Q4 2025.
Zoetis (ZTS) Interest Expenses (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Interest Expenses for 15 consecutive years, with $62.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 14.81% year-over-year to $62.0 million; the TTM figure through Mar 2026 stood at $170.0 million (down 37.04% YoY), while the FY2025 annual figure was $18853.4 billion, up 6880689.78% from the prior year.
- Interest Expenses rose to $62.0 million in Q1 2026 per ZTS's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Interest Expenses topped out at $100.0 million in Q4 2024 and bottomed at -$3.0 million in Q4 2025.
- Historically, Interest Expenses has averaged $61.2 million across 5 years, with a median of $59.0 million in 2023.
- Annual changes were most pronounced in 2024 — Interest Expenses soared 42.86% — and 2025, when it tumbled 103.0%.
- Zoetis' Interest Expenses stood at $62.0 million in 2022, then grew by 12.9% to $70.0 million in 2023, then jumped by 42.86% to $100.0 million in 2024, then slumped by 103.0% to -$3.0 million in 2025, then surged by 2166.67% to $62.0 million in 2026.
- Business Quant data shows ZTS's Interest Expenses at $62.0 million in Q1 2026, -$3.0 million in Q4 2025, and $58.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | 25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.00 Mn |
| Jun 30, 2026 | 61.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Sep 30, 2025 | 58.00 Mn |
| Sep 30, 2025 | 58.00 Mn |
| Jun 30, 2025 | 53.00 Mn |
| Jun 30, 2025 | 53.00 Mn |
| Mar 31, 2025 | 54.00 Mn |
| Mar 31, 2025 | 54.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Sep 30, 2024 | 57.00 Mn |
| Sep 30, 2024 | 57.00 Mn |
| Jun 30, 2024 | 59.00 Mn |
| Jun 30, 2024 | 59.00 Mn |
| Mar 31, 2024 | 68.00 Mn |
| Mar 31, 2024 | 68.00 Mn |